|
|
| (One intermediate revision by one other user not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Enalapril maleate]] |
| {{CMG}}
| |
| | |
| ===[[Enalapril maleate]] ([[Vasotec]])===
| |
| ===[[Enalapril maleate/Hydrochlorothiazide|Metoprolol succinate/Hydrochlorothiazide]] ===
| |
| | |
| ==Overview==
| |
| | |
| Enalapril is an [[angiontensin converting enzyme inhibitor]] that is FDA approved for the treatment of [[hypertension]], [[heart failure]], [[left ventricular dysfunction]] after [[myocardial infarction]], [[diabetic nephropathy]]. Adverse reactions include [[hyperkalemia]], [[dizziness]], increase in serum blood urea nitrogen, increase in serum creatinine, [[fatigue]].
| |
| | |
| The active substance metoprolol is employed either as ''enalapril [[maleic acid|maleate]]'' or as ''enalapril [[maleic acid|maleate]]'' and ''[[hydrochlorothiazide]]''.
| |
| | |
| ==Category==
| |
| | |
| angiontensin converting enzyme inhibitor, antihypertensive
| |